ArticleBMC infectious diseases2025
First identification of occult hepatitis B infection among ethnic minority students in Thai Nguyen, Vietnam.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B virus (HBV) remains a major health concern particularly in regions with intermediate-to-high endemicity such as Vietnam. Occult hepatitis B infection (OBI) defined as the presence of replication-competent HBV DNA in the absence of detectable hepatitis B surface antigen (HBsAg) poses challenges for diagnosis and blood safety. However, data on OBI among Vietnam's ethnic minority populations are scarce.
methodsA cross-sectional study was conducted among 267 HBsAg-negative ethnic minority students at Thai Nguyen University of Medicine and Pharmacy in 2024. Serum samples were screened for HBV serological markers (anti-HBs, anti-HBc) using commercial ELISAs. HBV DNA was extracted, amplified by nested PCR targeting a conserved S/P region, and sequenced for genotyping and mutational analysis. Quantitative real-time PCR (qPCR) was used to assess viral loads.
resultsAmong participants, 57% were susceptible (anti-HBs-/anti-HBc-), 27% exhibited vaccine-induced immunity, 12% had resolved infections, and 4% showed isolated anti-HBc positivity. Overall, 16% were anti-HBc positive, indicating prior exposure. HBV DNA was detected in two samples (0.7%), both with undetectable viral loads by qPCR. One case represented seronegative OBI and the other seropositive OBI. Phylogenetic analysis classified both isolates as genotype B. Mutational analysis identified substitutions K122R, F200Y, Y206C, and I187V, with S117N uniquely present in one isolate.
conclusionsThis study provides the first evidence of OBI among ethnic minority students in northern Vietnam. Although prevalence was low, the high proportion of HBV-susceptible individuals highlights ongoing vulnerability and underscores the need for strengthened immunization, awareness, and surveillance programs in underserved communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.